News

0.780

-0.020 (-2.5%)
Language:

The healthcare sector continues to demonstrate resilience, despite global challenges.
TheStar31 Jul, 2026 00:00am - 1 month

兴业投行发布的一项报告指出,今年首季属于传统淡季,加上农历新年与开斋节同期落在首季,导致住院率暂时放缓。...
Nanyang28 Jun, 2026 16:08pm - 2 months

The healthcare sector is expected to remain resilient through 2026 despite mounting inflationary pressures, geopolitical uncertainties and the prospect of upcoming elections, supported by the defensive nature of healthcare demand and the pricing power of hospital operators.
TheStar26 Jun, 2026 00:00am - 2 months

KUALA LUMPUR: Stocks to watch on Thursday include Vantris Energy Bhd, Scanwolf Corp Bhd, Widad Group Bhd, Hextar Technologies Solutions Bhd (HexTech), Beshom Holdings Bhd, Malaysian Resources Corp Bhd (MRCB) and LAC Med Bhd.
TheStar18 Jun, 2026 08:35am - 2 months

LAC Med Bhd's wholly-owned subsidiary, LAC Medical Supplies Sdn Bhd, has secured a RM78.9mil contract to supply and deliver reagents and related items for chemistry tests to public hospitals in Kedah.
TheStar17 Jun, 2026 00:00am - 2 months

A brief recap of some business news and corporate announcements that made the headlines on Tuesday.
TheEdge16 Jun, 2026 23:45pm - 2 months

LAC医疗接获医疗特许公司发出的中标函,获得总值高达7890万令吉的供应合约。...
Nanyang16 Jun, 2026 15:35pm - 2 months

(吉隆坡16日讯)LAC医疗(LACMED,5341,主板医疗保健组)获颁7889万1403令吉合约,为卫生部旗下吉打州10家医院供应和交付病理化学测试所需的试剂及相关物品。根据LAC医疗的文告,子公司LAC医疗供应私人有限公司昨日(15日)获颁上述合约的得标通知书(LOA),供应相关试剂及物品。LAC医疗指出,试剂及相关物品的交付取决于医院的实际使用需求,合同为期4年,自2026年6月15日起至2030年6月14日止。迄今为止,该公司已从同一品牌获得约1亿零570万令吉订单,让公司订单总...
Sinchew16 Jun, 2026 14:24pm - 2 months

(吉隆坡16日讯)LAC Med Bhd(KL:LACMED)获得价值高达7890万令吉的4年期合约,向吉打州10所卫生部医院供应病理化学检测所需的试剂及相关用品。
TheEdge16 Jun, 2026 14:05pm - 2 months

LAC Med Bhd (KL:LACMED) has secured a four-year contract worth up to RM78.9 million to supply reagents and related items for pathology chemistry tests to 10 Ministry of Health hospitals in Kedah.
TheEdge16 Jun, 2026 13:40pm - 2 months

KUALA LUMPUR: LAC Med Bhd has bagged a RM78.9mil contract for the supply of reagents with related items for pathology chemistry tests to 10 public hospitals under the Ministry of Health in Kedah.
TheStar16 Jun, 2026 13:04pm - 2 months

券商 :兴业投行研究投资建议 :买进闭市价 :80.5仙(截至5月25日)目标价 :1.14令吉每股收益 :8仙 (2027财年估计)本益比 :9.71倍(2027财年估计)股息收益率 :3.1%(2027财年估计)LAC Med集团( LACMED,5341,主要板医疗保健)正与多个新品牌供应商进行深入洽谈,盈利有望逐季改善,并且全年可维持约20%的业绩增长,因此我们将目标价维持在1.14令吉,意味仍有约43%上涨空间。截至目前,该公司持有总值约6亿9090万令吉标书,其中8...
Chinapress25 May, 2026 21:05pm - 3 months

KUALA LUMPUR: Healthcare companies with strong cost management are expected to benefit as Malaysia moves towards more transparent hospital billing and faces rising healthcare demand from an ageing population.
NST07 May, 2026 10:12am - 4 months

RHB Investment Bank Bhd (RHB IB) has selected five companies, namely Binastra Corp Bhd, Eco-Shop Marketing Bhd, Kelington Group Bhd, LAC Med Bhd, and MR DIY Group (M) Bhd, as its top environmental, social, and governance (ESG) investment "Diamonds in the Rough" for 2026.
TheStar08 Apr, 2026 00:00am - 5 months

KUALA LUMPUR: RHB Investment Bank Bhd (RHB IB) has selected five Malaysian companies, namely Binastra Corporation Bhd, Eco-Shop Marketing Bhd, Kelington Group Bhd, LAC Med Bhd, and MR DIY Group (M) Bhd, as its top environmental, social, and governance (ESG) investment "Diamonds in the Rough" for 2026.
TheStar07 Apr, 2026 12:46pm - 5 months

LAC医疗(LACMED,5341,主板医疗保健组)专注于提供医疗设备及软体系统整合等服务,分析员认为,随着经常收入基础扩大,该公司的盈利可见度已跟着增强。乐天交易分析员在报告中说,在大马医疗旅游年2026(MYMT 2026)政策带动之下,我国的目标是到2030年将医疗旅游收入从2024年的27亿2000万令吉提升至120亿令吉,这需要业者持续扩充医院及增加医疗设备投资。“LAC医疗拥有涵盖影像、诊断及资讯通讯科技(ICT)整合等11个品牌组合,有机会成为医院资本开销与营运开销供应链直接且...
Sinchew06 Apr, 2026 07:21am - 5 months

THE Securities Commission Malaysia (SC) is following the lead of regional counterparts in Japan, South Korea and Singapore by launching a “value up” programme to boost stock valua­tions in the local bourse. In the recently launched 4th Capital Market Master Plan (CMP4), SC announced the...
TheEdge30 Mar, 2026 14:00pm - 5 months

Malaysia's healthcare sector is expected to remain a preferred defensive play in 2026, underpinned by resilient domestic demand, rising revenue intensity and stronger earnings visibility.
TheStar26 Mar, 2026 00:00am - 5 months

马股保健股LAC Med(LACMED,5341,主板保健股)近期股价从1.25令吉高位回落至80仙水平,但基本面依然获得投行力挺。兴业投行在最新报告中指出,LAC Med不仅是大马医疗保健扩张的主要受益者,其不断增长的经常性收入更是一大亮点。特别是公司拿下了飞利浦(Philips)的MRI和CT扫描仪维修合约,这类大型设备服务费极具吸引力。此外,集团在印尼的扩展步伐加快,版图已延伸至苏门答腊和泗水等地。管理层指出,虽然面临潜在的通胀压力,但成本可转嫁给客户。投行认为,近...
Nanyang14 Mar, 2026 18:00pm - 5 months

乐天交易研究主管余贤彬在今日的线上汇报会中指出,在目前水平下,大马经济整体仍有能力应对油价上涨,并且相较一些区域国家,大马的抗冲击能力更强。...
Nanyang13 Mar, 2026 16:16pm - 5 months